Atherosclerotic Cardiovascular Disease
📧 Sign up to get email alerts when something new happens for Atherosclerotic Cardiovascular Disease.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2016-10-31FDA Approved: ROSUVASTATIN CALCIUM — Original Application (Torrent Pharmaceuticals Limited)
FDA approved an Original Application for rosuvastatin calcium from Torrent Pharmaceuticals Limited, granting generic approval for the rosuva…
-
FDA approval · 2016-10-31FDA Approved: ROSUVASTATIN — Original Application (Camber Pharmaceuticals, Inc.)
FDA approves rosuvastatin (generic) under an Original Application by Camber Pharmaceuticals, adding a generic statin option for lowering cho…
-
FDA approval · 2016-10-31FDA Approved: ROSUVASTATIN CALCIUM — Original Application (PURACAP LABORATORIES LLC DBA BLU PHARMACEUTICALS)
FDA approved an original ANDA for rosuvastatin calcium, enabling a generic version of rosuvastatin calcium manufactured by Puracap Laborator…
-
FDA approval · 2016-10-31FDA Approved: ROSUVASTATIN CALCIUM — Original Application (Westminster Pharmaceuticals, LLC)
FDA approved the Original Application for rosuvastatin calcium from Westminster Pharmaceuticals, LLC, granting a generic rosuvastatin calciu…
-
FDA approval · 2016-07-19FDA Approved: ROSUVASTATIN CALCIUM — Original Application (Glenmark Pharmaceutials Inc., USA)
FDA approves rosuvastatin calcium as an original generic application from Glenmark Pharmaceuticals Inc., USA.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2016-07-19FDA Approved: ROSUVASTAIN CALCIUM — Original Application (Chartwell RX, LLC)
FDA approves ROSUVASTAIN CALCIUM as an original generic (ANDA) application for rosuvastatin calcium. The approval enables marketing of this …
-
FDA approval · 2016-07-19FDA Approved: ROSUVASTATIN CALCIUM — Original Application (Rising Pharma Holdings, Inc.)
FDA approved an original Abbreviated New Drug Application for rosuvastatin calcium from Rising Pharma Holdings, Inc.
-
FDA approval · 2016-05-19FDA Approved: ATORVASTATIN CALCIUM — Original Application (Cipla USA Inc.,)
The FDA approved Cipla USA Inc.'s atorvastatin calcium tablet as an Original Application, enabling a generic atorvastatin calcium product to…
-
FDA approval · 2016-05-05FDA Approved: SIMVASTATIN — Supplemental Application (Biocon Pharma Inc,)
FDA approved Biocon Pharma Inc.'s supplemental application for simvastatin (ANDA 078034). This confirms an approved modification to the gene…
-
FDA approval · 2016-02-24FDA Approved: ATORVASTATIN CALCIUM — Supplemental Application (Dr. Reddy's Laboratories Limited)
FDA approved a supplemental application for atorvastatin calcium from Dr. Reddy's Laboratories Limited, authorizing the generic atorvastatin…
-
FDA approval · 2016-01-27FDA Approved: FLUVASTATIN SODIUM — Original Application (Teva Pharmaceuticals USA, Inc.)
FDA approved Teva's generic fluvastatin sodium as an original ANDA, enabling its use to treat hyperlipidemia and reduce cardiovascular risk.
-
FDA approval · 2015-11-30FDA Approved: PRAVASTATIN SODIUM — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for pravastatin sodium from Teva Pharmaceuticals USA, Inc., authorizing a generic pravastatin produc…
-
FDA approval · 2015-11-09FDA Approved: ATORVASTATIN CALCIUM — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for atorvastatin calcium (generic) by Mylan Pharmaceuticals, confirming an additional aspect of its …
-
FDA approval · 2015-10-15FDA Approved: SIMVASTATIN — Supplemental Application (NorthStar Rx LLC)
The FDA approved a supplemental application for simvastatin submitted by NorthStar Rx LLC.
-
FDA approval · 2015-10-06FDA Approved: ATORVASTATIN CALCIUM — Supplemental Application (Sun Pharmaceutical Industries Inc.)
The FDA approved a supplemental application for atorvastatin calcium from Sun Pharmaceutical Industries Inc., granting regulatory approval f…
-
FDA approval · 2015-07-24FDA Approved: PRALUENT — Original Application (Regeneron Pharmaceuticals, Inc.)
FDA approved the original application for PRALUENT (alirocumab) by Regeneron. It is indicated to lower LDL cholesterol in adults with hetero…
-
EMA approval · 2015-07-24Praluent recommended for approval to lower cholesterol
The European Medicines Agency recommended approval of Praluent (alirocumab) to lower cholesterol, pursuing a new indication.
-
FDA approval · 2015-07-09FDA Approved: NIACIN — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for NIACIN (nicotinic acid) from Sun Pharmaceutical Industries, Inc., relating to an additional appr…
-
FDA approval · 2015-06-01FDA Approved: CRESTOR — Supplemental Application (AstraZeneca Pharmaceuticals LP)
FDA approved a supplemental application for CRESTOR (rosuvastatin) submitted by AstraZeneca Pharmaceuticals LP.
-
EMA approval · 2015-05-22First-in-class treatment to lower cholesterol
EMA announces a first-in-class treatment to lower cholesterol, representing a novel mechanism for managing the condition.
-
FDA approval · 2015-04-28FDA Approved: ATORVASTATIN CALCIUM — Supplemental Application (Quallent)
FDA approved a supplemental application for atorvastatin calcium (Quallent).
-
FDA approval · 2015-04-15FDA Approved: PRAVASTATIN SODIUM — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for Pravastatin Sodium submitted by Aurobindo Pharma Limited, approving this generic statin product.
-
FDA approval · 2015-04-06FDA Approved: ATORVASTATIN CALCIUM — Supplemental Application (Quallent)
The FDA approved a supplemental application for atorvastatin calcium from Quallent, granting updated regulatory approval for this generic st…
-
FDA approval · 2014-12-01FDA Approved: LOVASTATIN — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approved a supplemental application for Lovastatin by Lupin Pharmaceuticals, Inc., resulting in regulatory approval related to the gener…
-
FDA approval · 2014-12-01FDA Approved: LOVASTATIN — Supplemental Application (Carlsbad Technology, Inc.)
FDA approved a supplemental application for Lovastatin from Carlsbad Technology, Inc., expanding access to a generic statin.